Patient must have valid Social Security number to apply for assistance and receive treatment in the United States.
Patient income must be at or below 500% of the Federal Poverty Level (FPL.)
Patient is required to have insurance coverage which covers at least 50% of the cost of treatment.
Patient must be diagnosed with a covered disease and program must be accepting enrollments.
Patient must be seeking assistance for a prescribed medication that is FDA approved to treat the covered diagnosis.
Abraxane
Alecensa
Alimta
Alunbrig
Alymsys
Augtyro
Avastin
Avzivi
Beizray
Bizengri
Braftovi
Cyramza
Datroway
Docetaxel
Docivyx
Emrelis
Enhertu
Ensacove
Erlotinib
Gavreto
Gefitinib
Gemcitabine Hydrochloride
Gilotrif
Hernexeos
Ibtrozi
Imfinzi
Imjudo
Iressa
Jobevne
Keytruda
Keytruda Qlex
Krazati
Lazcluze
Libtayo
Lorbrena
Lumakras
Mekinist
Mektovi
Methotrexate
Mvasi
Onxol
Opdivo
Opdivo Qvantig
Optune Lua
Paclitaxel
Pemetrexed
Pemfexy
Portrazza
Retevmo
Rozlytrek
Rybrevant
Tabrecta
Tafinlar
Tagrisso
Taxotere
Tecentriq
Tecentriq Hybreza
Tepmetko
Trexall
Vegzelma
Vinorelbine Tartrate
Vizimpro
Xalkori
Yervoy
Zegfrovy
Zirabev
Zykadia
Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung. Non-small cell lung cancer is the most common kind of lung cancer. (Source: NIH; National Cancer Institute)
Eligibility Criteria
Patient must have valid Social Security number to apply for assistance and receive treatment in the United States.
Patient income must be at or below 500% of the Federal Poverty Level (FPL.)
Patient is required to have insurance coverage which covers at least 50% of the cost of treatment.
Patient must be diagnosed with a covered disease and program must be accepting enrollments.
Patient must be seeking assistance for a prescribed medication that is FDA approved to treat the covered diagnosis.
Medications Covered
Abraxane
Alecensa
Alimta
Alunbrig
Alymsys
Augtyro
Avastin
Avzivi
Beizray
Bizengri
Braftovi
Cyramza
Datroway
Docetaxel
Docivyx
Emrelis
Enhertu
Ensacove
Erlotinib
Gavreto
Gefitinib
Gemcitabine Hydrochloride
Gilotrif
Hernexeos
Ibtrozi
Imfinzi
Imjudo
Iressa
Jobevne
Keytruda
Keytruda Qlex
Krazati
Lazcluze
Libtayo
Lorbrena
Lumakras
Mekinist
Mektovi
Methotrexate
Mvasi
Onxol
Opdivo
Opdivo Qvantig
Optune Lua
Paclitaxel
Pemetrexed
Pemfexy
Portrazza
Retevmo
Rozlytrek
Rybrevant
Tabrecta
Tafinlar
Tagrisso
Taxotere
Tecentriq
Tecentriq Hybreza
Tepmetko
Trexall
Vegzelma
Vinorelbine Tartrate
Vizimpro
Xalkori
Yervoy
Zegfrovy
Zirabev
Zykadia
Disease Description
Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung. Non-small cell lung cancer is the most common kind of lung cancer. (Source: NIH; National Cancer Institute)